Skip to content
|
Follow Us
My Account
🏠 Home
World
India
USA
Business
Sports
Technology
Lifestyle
Contact
Zydus eyes Q4 FY27 US launch for liver disease drug after FDA review
May 28, 2026
·
Business & Economy
Sudhir Choudhary
The US FDA has granted priority review to Saroglitazar, Zydus Lifesciences’ drug for treating Primary Biliary Cholangitis
corporate news
finance
global economy
international markets
trade
world business
Other Posts
Voting Underway for 24 Rajya Sabha Seats Across 10 States as Key Political Leaders Near End of Terms
June 18, 2026
PM Narendra Modi Arrives in Paris After High-Stakes G7 Diplomacy, Holds Key Talks with President Donald Trump
June 18, 2026
Opposition Faces Fresh Political Turmoil as Shiv Sena (UBT) Defection Claims Grow and TMC Confronts Internal Dispute
June 18, 2026
Indian Air Force Flies Over 200 Sorties to Secure NEET-UG Re-Exam Papers as Telegram Faces Temporary Restrictions
June 18, 2026
←
Canada’s Current Account Deficit Surged in First Quarter as Imports Rose
Iran targets US air base after US strikes strain ceasefire
→
Latest Updates
